Results 241 to 250 of about 30,003 (287)

Generics, Biosimilars and Follow-On Non-Biologic Complex Drugs for Multiple Sclerosis: A Narrative Review of the Regulatory and Clinical Implications for European Neurologists. [PDF]

open access: yesEur J Neurol
Berger T   +12 more
europepmc   +1 more source

Accelerating Earlier Access to Anti-TNF-α Agents with Biosimilar Medicines in the Management of Inflammatory Bowel Disease. [PDF]

open access: yesJ Clin Med
Fiorino G   +7 more
europepmc   +1 more source

Biosimilars: Current regulatory perspective and challenges

open access: gold, 2013
Diwakar Jha   +2 more
openalex   +1 more source

What role for real-world evidence in market access of biosimilars? [PDF]

open access: yesFront Pharmacol
Simoens S, Lockhart CM, Courmier DF.
europepmc   +1 more source

A Methodological Proposal for Health Technology Assessments: A Case Study on Biosimilar Drugs. [PDF]

open access: yesJ Mark Access Health Policy
Dimmito MP   +10 more
europepmc   +1 more source

Anti-Adalimumab Antibodies Purified from Juvenile Idiopathic Arthritis Patients: Kinetic Characterization Among Biosimilars. [PDF]

open access: yesBiosensors (Basel)
Di Santo A   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy